Page 2878 - Markets News

Street signs: Broker lobbies integrate, India and EMs diverge, and more

What has played in India's favour this year is exactly what has gone against the EM index

Rupee slide nearing its end, RBI likely to step in, say economists

The rupee should consolidate around the present level, but global sentiments could push it back to 72-72.5 a dollar level

Many reasons why Bajaj Finance stock will remain an outperformer

Strong loan growth thanks to increasing aspirational buyers and healthy asset quality could keep story intact

FMCG to auto, higher growth in rural sales captures spirit of New India

Sale of FMCG items in rural India - home to over two-thirds of the country's population is now growing at 28 per cent higher than urban areas

Indian equities are off to best start to a financial year since Modi win

India is already among the best-performing markets globally this fiscal year

Pharma funds make a comeback; now rises 17.3% for a one-year period

Attractive valuations have spurred fund houses to launch new funds in this category as well

Our June 2019-end target for Nifty50 index is 11,892: Saion Mukherjee

SAION MUKHERJEE, head of India equity research at Nomura, tells Puneet Wadhwa that though it seems unlikely that just the current rupee depreciation can trigger a sell-off

7 of top 10 most valued cos add Rs 762 bn in m-cap, HDFC biggest gainer

The seven firms Tata Consultancy Services (TCS), HDFC Bank, ITC, HDFC, Infosys, SBI and Kotak Mahindra Bank saw rise in their valuation

India Inc's foreign borrowing rises 74% to $3.5 billion in July

Of the total borrowings (ECB), $1.75 billion was raised through automatic route and rest from approval route of the ECB

Foreign investors remain bullish on India, infuse Rs 51-bn in August

Overall, so far this year, overseas investors have pulled nearly Rs 24 billion from equities and close to Rs 380 billion from the debt markets

Market wrap: Rupee breaches 71 a dollar, Sensex, Nifty at all-time highs

Sensex rallied 393.27 points to close at 38645.07, while the broader Nifty rose 123.40 point to finish at 11,680.50

Tomato prices fall to Rs 2 per kg; farmers unable to recover transport cost

Farmers irked, say they are unable to recover even transport cost

Uncertainty over Rana Kapoor's reappointment is 'big negative' for YES Bank

Analysts at Macquarie suggest that anything short of a full three-year term for Kapoor will be taken negatively by investors

Amfi issues guidelines for cyber security and privacy of user data

Markets regulator Securities and Exchange Board of India (Sebi) had in the past directed the players to follow the 'best practices' guidelines laid down by Amfi

A fall in Indian stock mkt will be a buying opportunity: CLSA's Chris Wood

Besides India, which Wood believes is a 'buy on dips market', he finds Pakistan's equity market as an attractive investment destination

TCS regains its status as India's most valued firm by market cap

At close of trade on Friday, the market capitalisation (m-cap) of TCS stood at Rs 7956.5 billion, which is Rs 91.83 billion more than that of RIL

Rupee falls 26 paise to hit record low; breaches 71-mark for first time

Growing fears about rising inflation in amid high global crude oil prices and consistent outflow of foreign funds from the domestic equity market also weighed on the domestic currency

MARKET WRAP: Sensex slips 45 pts, RIL falls 2.75%; Rupee hits all-time low

Among sectoral indices, the Nifty Pharma index rose 2.7 per cent led by a rise in Lupin and Dr. Reddy's Laboratories. The Nifty IT index, too, settled 1.8 per cent higher.

L&T hits over two-month high; stock up 11% in two weeks

The stock was up 2% at Rs 1,374 on the BSE, its highest level since June 4, 2018.

Nifty Pharma index set to post sharpest monthly rally in 9 years

Nifty Pharma index hit a fresh 52-week high of 10,390 in intra-day on Friday, rallying 13% thus far in the month of August, its sharpest monthly gain since September 2009.